Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of GONB and PRF in Chronic Migraine
NCT07512219Not yet recruiting
- Sponsor
- Sohag University
- Start
- May 2026
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
01
Overview
Randomised trial of ropivacaine and triamcinolone in chronic migraine (2 arms), sponsored by Sohag University. Primary endpoint: Visual Analog Scale score of Pain at 6 months. Planned start May 2026; status: not yet recruiting.
02
Drugs
ropivacainetriamcinolone
03
Conditions
chronic migraine
Beyond the preview
Go deeper on NCT07512219.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07512219.